Drugs / Rivoglitazone
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01118754 | Apr → Dec 2010 | dry eye syndrome | Santen Inc. | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT01468168 | Oct 2011 → Nov 2012 | dry eye syndrome | Santen Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00575874 | Aug 2007 → Jun 2008 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2 | NCT00575471 | Jul 2007 → Mar 2008 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00143520 | Dec 2004 → Dec 2005 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00571519 | Nov 2007 → May 2008 | type 2 diabetes mellitus | Daiichi Sankyo | Terminated | No outcome recorded |
| Phase 3 | NCT00484198 | Apr 2007 → Feb 2009 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rivoglitazone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00575874 ↗ |
| Known as | CS-011 | “A Randomized, Double-blind, Double-dummy, Placebo-controlled 26-week Dose-response Study of Rivoglitazone HCl (CS-011) With Active Comparator (Pioglitazone HCl) in Subjects...” NCT00143520 ↗1“A Randomized, Double-Blind, Placebo-Controlled 12-Week Dose-Response Study of Rivoglitazone (CS-011) in Patients With Type 2 Diabetes.” NCT00575471 ↗ |
| Known as | DE-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01468168 ↗ |
| Known as | R 106056 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104753 ↗ |
| Known as | Rivoglitazona | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104753 ↗ |
| Known as | Rivoglitazone HCl | “A Randomized, Double-blind, Double-dummy, Placebo-controlled 26-week Dose-response Study of Rivoglitazone HCl (CS-011) With Active Comparator (Pioglitazone HCl) in Subjects...” NCT00143520 ↗1“rivoglitazone HCl 0.5mg” NCT00571519 ↗ |
| Action | Activate | “Peroxisome proliferator-activated receptor gamma agonist” CHEMBL2104753 ↗ |
| Modality | Small molecule | “rivoglitazone, a novel thiazolidinedione” PMID 20370378 ↗ Jun 2010 |
| Route | Oral | “1.0 mg tablet administered orally, once daily” NCT00484198 ↗ |
| Target | PPARG | “Peroxisome proliferator-activated receptor gamma agonist” CHEMBL2104753 ↗ |